Incidence and Distribution of Subepidermal Autoimmune Bullous Skin Diseases in Three French Regions, Archives of Dermatology, vol.131, issue.1, pp.48-52, 1995. ,
DOI : 10.1001/archderm.1995.01690130050009
Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany, Archives of Dermatology, vol.131, issue.8, pp.957-965, 1995. ,
DOI : 10.1001/archderm.131.8.957
Annual incidence and mortality of bullous pemphigoid in the Grampian Region of North-east Scotland, British Journal of Dermatology, vol.48, issue.2, pp.424-431, 2005. ,
DOI : 10.1177/002215540004800411
Incidence and Mortality of Bullous Pemphigoid in France, Journal of Investigative Dermatology, vol.132, issue.8, 1998. ,
DOI : 10.1038/jid.2012.35
URL : https://hal.archives-ouvertes.fr/hal-00729013
Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study, BMJ, vol.337, issue.jul09 1, p.180, 2008. ,
DOI : 10.1136/bmj.a180
Increased risk of bullous pemphigoid in male and very old patients: A population-based study on incidence, Journal of the American Academy of Dermatology, vol.41, issue.2, pp.266-274, 1999. ,
DOI : 10.1016/S0190-9622(99)70061-7
A Comparison of Oral and Topical Corticosteroids in Patients with Bullous Pemphigoid, New England Journal of Medicine, vol.346, issue.5, pp.321-328, 2002. ,
DOI : 10.1056/NEJMoa011592
A Comparison of Oral Methylprednisolone Plus Azathioprine or Mycophenolate Mofetil for the Treatment of Bullous Pemphigoid, Archives of Dermatology, vol.143, issue.12, pp.1536-1578, 2007. ,
DOI : 10.1001/archderm.143.12.1536
Neurological Disorders in Patients with Bullous Pemphigoid, Dermatology, vol.124, issue.3, pp.187-91, 2007. ,
DOI : 10.1176/appi.ps.54.1.92
Clinical presentation and diagnostic delay in bullous pemphigoid: a prospective nationwide cohort, British Journal of Dermatology, vol.131, issue.5, pp.1111-1118, 2012. ,
DOI : 10.1038/jid.2010.357
High Risk of Death in Elderly Patients With Extensive Bullous Pemphigoid, Archives of Dermatology, vol.134, issue.4, pp.465-474, 1998. ,
DOI : 10.1001/archderm.134.4.465
Risk Factors for Lethal Outcome in Patients With Bullous Pemphigoid, Archives of Dermatology, vol.138, issue.7, pp.903-911, 2002. ,
DOI : 10.1001/archderm.138.7.903
How to Validate Outcome Instruments for Pemphigus, Journal of Investigative Dermatology, vol.129, issue.10, pp.2328-2358, 2009. ,
DOI : 10.1038/jid.2009.228
URL : https://doi.org/10.1038/jid.2009.228
The Association of Bullous Pemphigoid With Cerebrovascular Disease and Dementia, Archives of Dermatology, vol.146, issue.11, pp.1251-1255, 2010. ,
DOI : 10.1001/archdermatol.2010.322
Whole body application of a potent topical corticosteroid for bullous pemphigoid, Journal of the European Academy of Dermatology and Venereology, vol.23, issue.6, pp.712-720, 2014. ,
DOI : 10.3109/09546634.2010.534127
Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial, The Lancet, vol.389, issue.10079, pp.1630-1638, 2017. ,
DOI : 10.1016/S0140-6736(17)30560-3
URL : https://doi.org/10.1016/s0140-6736(17)30560-3
Low-dose methotrexate treatment in elderly patients with bullous pemphigoid, Journal of the American Academy of Dermatology, vol.31, issue.4, pp.620-625, 1994. ,
DOI : 10.1016/S0190-9622(94)70227-6
Combined treatment with low-dose methotrexate and initial short-term superpotent topical steroids in bullous pemphigoid: an open, multicentre, retrospective study, British Journal of Dermatology, vol.ii, issue.6, pp.1337-1380, 2011. ,
DOI : 10.1016/S0140-6736(84)92565-0
Controlled Trial of Azathioprine and Plasma Exchange in Addition to Prednisolone in the Treatment of Bullous Pemphigoid, Archives of Dermatology, vol.129, issue.1, pp.49-53, 1993. ,
DOI : 10.1001/archderm.1993.01680220061016
Evaluation of Clinical Criteria for Diagnosis of Bullous Pemphigoid, Archives of Dermatology, vol.134, issue.9, pp.1075-80, 1998. ,
DOI : 10.1001/archderm.134.9.1075
Clinical Criteria for the Diagnosis of Bullous Pemphigoid: A Reevaluation according to Immunoblot Analysis of Patient Sera, Dermatology, vol.208, issue.1, pp.16-20, 2004. ,
DOI : 10.1159/000075040
Evaluation of histological criteria for bullous pemphigoid. Correlation with antigens recognized by immunoblotting of anti-epidermal autoantibodies], Ann Pathol. déc, vol.20, issue.6, pp.564-573, 2000. ,
Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts, Journal of the American Academy of Dermatology, vol.66, issue.3, pp.479-85, 2012. ,
DOI : 10.1016/j.jaad.2011.06.032
A Comparison of Two Regimens of Topical Corticosteroids in the Treatment of Patients with Bullous Pemphigoid: A Multicenter Randomized Study, Journal of Investigative Dermatology, vol.129, issue.7, pp.1681-1688, 2009. ,
DOI : 10.1038/jid.2008.412
URL : https://hal.archives-ouvertes.fr/hal-00396990